A Study to Evaluate Safety and Immunogenicity of Sequential Vaccination of Sabin Inactivated Poliomyelitis Vaccine (Vero Cell) and Live Attenuated Poliomyelitis Vaccine in Healthy 2-month-old Infants

PHASE3CompletedINTERVENTIONAL

Enrollment

300

Participants

Timeline

Start Date

March 8, 2023

Primary Completion Date

April 12, 2024

Study Completion Date

April 12, 2024

Conditions

Poliomyelitis

Interventions

BIOLOGICAL

sIPV+bOPV

"2+1 sequential immunization program (sIPV-sIPV-bOPV)"

BIOLOGICAL

wIPV+bOPV

"2+1 sequential immunization program (wIPV-wIPV-bOPV)"

Trial Locations (1)

Shandong Provincial Center for Diseases Control and Prevention, Jinan